AFFERA, INC.
Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia, a prevalent condition affecting millions of patients worldwide.
AFFERA, INC.
Social Links:
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.affera.com
Total Employee:
11+
Status:
Active
Contact:
+1 857-304-4030
Email Addresses:
[email protected]
Total Funding:
5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag Mobile Non Scaleable Content HSTS
Similar Organizations
Aer Therapeutics
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Cognito Therapeutics
Cognito Therapeutics is a focused on discovering and developing new Alzheimer's treatments and preventive therapies.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Mirvie
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Stratus Medical
Stratusยฎ Medical's mission is to improve clinical outcomes for chronic pain patients by advancing RF technology for the treatment of pain.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Tridiuum
Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.
Walden Biosciences
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innogest Capital
Innogest Capital investment in Venture Round - Affera, Inc.
Norwich Ventures
Norwich Ventures investment in Series A - Affera, Inc.
BAMCAP
BAMCAP investment in Series A - Affera, Inc.
Official Site Inspections
http://www.affera.com Semrush global rank: 8.4 M Semrush visits lastest month: 537
- Host name: 180.241.167.72.host.secureserver.net
- IP address: 72.167.241.180
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260

More informations about "Affera, Inc."
Affera, Inc. โ Innovative Solutions for the Treatment of Cardiac โฆ
Apr 24, 2023 Doron is the founder and CEO of Affera, Inc. Prior to Affera, Doron co-founded and served as co-CEO at Rhythmia Medical, which developed a unique Electroanatomical Mapping System for the treatment of Cardiac Arrhythmia. Acquired by Boston Scientific in 2012, Rhythmia became Boston Scientificโs cardiac mapping and navigation division, where ...See details»
Affera, Inc. Management Team | Org Chart - RocketReach
Affera, Inc. employs 13 employees. The Affera, Inc. management team includes Victoria Low (Senior Manager, Clinical Program Management), and Paul Hultz (Senior Engineering โฆSee details»
Affera, Inc. - Crunchbase Company Profile & Funding
Affera, Inc. may be growing as it has been acquired by a larger company, which typically indicates a positive valuation and a strategic fit for the acquirer's portfolio. The acquisition is aimed at expanding the acquirer's cardiac ablation portfolio, suggesting that Affera's offerings are valuable and complementary to existing products in the market.See details»
Medtronic to Acquire Affera - Newswire
Jan 10, 2022 "Bringing Affera into our organization, with our established footprint in the cardiac ablation space, will strengthen our ability to provide innovative therapies and enable Medtronic โฆSee details»
Medtronic completes acquisition of Affera | Markets Insider
Aug 30, 2022 Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing demands for cardiac arrhythmia treatment. โฆSee details»
Affera 2025 Company Profile: Valuation, Investors, Acquisition
Affera General Information Description. Developer of a medical device designed to treat heart rhythm disorders. The company is engaged in the design and development of a novel medical system for the treatment of heart rhythm disorders, enabling healthcare institutions to address the unmet needs in cardiac arrhythmia treatment.See details»
Affera, Inc. Company Profile | Newtonville, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Affera, Inc. of Newtonville, MA. Get the latest business insights from Dun & Bradstreet.See details»
Medtronic acquires Affera, Inc. - 2022-01-10 - Crunchbase
Affera, Inc. Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. Acquiring Organization: Medtronic Medtronic is a โฆSee details»
Medtronic to Buy Affera for Nearly $1B | Twin Cities โฆ
Jan 11, 2022 Citing analysts at Minneapolis-based investment firm Piper Sandler, the Star Tribune reported that the transaction will cost Medtronic $925 million. โBringing Affera into our organization, with ...See details»
Affera, Inc. - Funding, Financials, Valuation & Investors - Crunchbase
Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. New. Resources. Advanced Search. ... How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2021: Venture Round ...See details»
Affera - Products, Competitors, Financials, Employees, โฆ
Affera is a medical technology company that designs and manufactures cardiac mapping and navigation systems, catheter-based cardiac ablation technologies, and focal pulsed field โฆSee details»
Affera, Inc. - Contacts, Employees, Board Members ... - Crunchbase
Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. ... Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AI . Organization. Affera, Inc. Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar ...See details»
Affera Company Profile - Office Locations, Competitors, Revenue โฆ
Affera has 5 employees across 2 locations. See insights on Affera including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Affera - Ownership and Business Overview - Mergr
Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing demands for cardiac arrhythmia treatment. Affera is developing a โฆSee details»
Medtronic to Acquire Affera for Undisclosed Amount
Jan 10, 2022 โThe EP [electrophysiology] ablation market is an exciting and fast-moving segment of cardiology. Bringing Affera into our organization, with our established footprint in โฆSee details»
Medtronic acquires Affera - Today's Medical Developments
Jan 16, 2022 โBringing Affera into our organization, with our established footprint in the cardiac ablation space, will strengthen our ability to provide innovative therapies and enable Medtronic entry into additional EP technology segments, such as mapping and navigation, for the first time.โ ... Afferaโs product portfolio is not currently approved ...See details»
Medtronic to Acquire Affera - Jan 10, 2022
Jan 10, 2022 "Bringing Affera into our organization, with our established footprint in the cardiac ablation space, will strengthen our ability to provide innovative therapies and enable Medtronic โฆSee details»
Medtronic completes acquisition of Affera - Newswire
Aug 30, 2022 In December 2021, Affera announced the commencement of the recently approved SPHERE Per-AF Trial, a U.S. Food and Drug Administration Investigational Device โฆSee details»
Medtronic Acquires Affera to Add Mapping and Navigation โฆ
Sep 2, 2022 Following the announcement of Medtronic's acquisition of Affera, here Rebecca Seidel, President, Cardiac Ablation Solutions, Medtronic discusses the burden presented by โฆSee details»
Medtronic Announces Aquisition of Affera - Surgical Robotics โฆ
Medtronic has announced that it has entered into a definitive agreement to acquire Affera, Inc., a Boston area-based, privately held medical technology company.Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the treatment of patients with โฆSee details»